Applying New Data in Practice:

This program will include a discussion of data that were presented in abstract form. These data should be considered preliminary until published in a peer-reviewed journal.

Goal: How do the DAPT guidelines and the latest clinical trial data for ACS management fit into practice?

2016 ACC/AHA DAPT Guidelines P2Y12 Inhibitor Selection

2016 ACC/AHA DAPT Guidelines DAPT Duration

2017 ESC Update on DAPT in CAD P2Y12 Inhibitor Selection and Timing

2017 ESC Update on DAPT in CAD P2Y12 Inhibitor Selection and Timing (cont)

2017 ESC Update on DAPT in CAD Methods to Minimize Bleeding With DAPT

More Potent P2Y12 Inhibitors Are Recommended but Are Underused…

ARTEMIS Study Design

ARTEMIS Clinicians Are Sensitive to Patient Costs

ARTEMIS Nonpersistence of P2Y12 Inhibitor

ARTEMIS MACE and As-Treated Analysis

ARTEMIS Conclusions

ARTEMIS: Clinical Implications

30-Day vs 90-Day Prescription Supply Study (1-Year Adherence)

ARTEMIS Voucher Use

TREAT Study

TREAT Study Principal Findings (30 Days)

TREAT Study Clinical Implications

SWAP-4 Study Design

SWAP-4 Study Results and Conclusions

Conclusion

Website References

Abbreviations

Abbreviations (cont)